Credit Agricole’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-150,000
Closed -$3.82M 1298
2025
Q3
$3.82M Buy
+150,000
New +$3.7M 0.01% 618
2025
Q1
$3.8M Sell
150,000
-200,000
-57% -$5.23M 0.01% 592
2024
Q4
$9.29M Hold
350,000
0.03% 408
2024
Q3
$10.1M Buy
350,000
+269,018
+332% +$7.85M 0.04% 281
2024
Q2
$2.27M Sell
80,982
-169,018
-68% -$4.65M 0.01% 536
2024
Q1
$6.35M Sell
250,000
-1,275,000
-84% -$35.4M 0.07% 227
2023
Q4
$43.9M Buy
1,525,000
+1,450,000
+1,933% +$43.8M 0.5% 41
2023
Q3
$2.49M Buy
75,000
+66,562
+789% +$2.35M 0.04% 259
2023
Q2
$310K Buy
+8,438
New +$328K 0.01% 393
2023
Q1
Sell
-47,334
Closed -$2.43M 733
2022
Q4
$2.43M Buy
+47,334
New +$2.27M 0.05% 222
2020
Q4
Sell
-16,864
Closed -$587K 612
2020
Q3
$587K Buy
+16,864
New +$591K 0.03% 218

Other funds holding PFE

Credit Agricole's PFE Position: Q2 2026 in Review

Credit Agricole increased its Pfizer (PFE) stake by 122% in Q2 2026, buying an estimated $37.9M and bringing the position to 2,635,085 shares worth $63.5M. The position accounts for 0.13% of the portfolio, ranked #132.

Credit Agricole first reported a position in PFE in Q3 2013 and has held it in 51 quarters since. The position peaked at $434M in Q3 2017. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Credit Agricole held 2,635,085 shares of Pfizer worth $63.5M as of Q2 2026.
  • Credit Agricole bought 1,449,064 Pfizer shares in Q2 2026, an estimated $37.9M.
  • Pfizer made up 0.13% of Credit Agricole's portfolio in Q2 2026, its #132 holding.
  • Credit Agricole first reported a position in Pfizer in Q3 2013 and has held it in 51 quarters since.
  • Credit Agricole's Pfizer position peaked at $434M in Q3 2017.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.